Skip to main content
. 2019 Aug;11(8):3325–3335. doi: 10.21037/jtd.2019.08.44

Table 2. Clinical outcomes.

Outcome Pre-protocol (n=72) Post-protocol (n=51) P value
Major bleeding 50 (69.4) 34 (66.7) 0.85
   Hgb drop ≥4 g/dL 10 (13.9) 5 (9.8) 0.50
   >2 pRBC units/day 48 (66.7) 34 (66.7) 1.00
   Retroperitoneal bleed 11 (15.3) 1 (2.0) 0.01
   Pulmonary or CNS bleed 10 (13.9) 2 (3.9) 0.07
   Surgical intervention 9 (12.5) 3 (5.9) 0.22
Minor bleeding 6 (8.3) 5 (9.8) 0.78
Thrombosis 15 (20.8) 14 (27.5) 0.39
   Circuit thrombosis 8 (11.1) 9 (17.6) 0.30
   DIC 6 (8.3) 7 (13.7) 0.34
   Ischemic stroke 4 (5.6) 1 (2.0) 0.32
   Pulmonary embolism 1 (1.4) 0 (0.0) 0.40
   Deep vein thrombosis 3 (4.2) 0 (0.0) 0.14
   Arterial thrombosis 3 (4.2) 1 (2.0) 0.50
ICU length of stay (days) 23.5±43.5 21.4±18.2 0.80
Mortality (in-hospital) 52 (72.2) 29 (56.9) 0.07
Mortality (on ECMO) 41 (56.9) 17 (33.3) 0.01

Data are presented as mean ± SD or as n (%). Hgb, hemoglobin; pRBC, packed red blood cells; CNS, central nervous system; DIC, disseminated intravascular coagulation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation; SD, standard deviation.